Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Margot Zöller

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2030-8307; OpenAlex author ID A5109072042. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 9)
Trials
0
Grants
0
Labs led
2
Collaborators
14
Papers, trials and grants by year

2013: 3 papers · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 12

  1. Retraction Note: Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming. Last author DOI 10.1186/s13046-025-03339-1↗
  2. Correction: Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming. Last author DOI 10.1186/s13046-024-03216-3↗
  3. The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery. Last author DOI 10.1155/2019/3516973↗
  4. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming. Last author DOI 10.1186/s13046-019-1129-8↗
  5. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression. Last author DOI 10.3389/fonc.2019.01359↗
  6. Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer. Last author DOI 10.1080/2162402x.2017.1319044↗
  7. Progress and potential of exosome analysis for early pancreatic cancer detection. First author DOI 10.1080/14737159.2016.1187563↗
  8. Pancreatic cancer stem cell markers and exosomes - the incentive push. Last author DOI 10.3748/wjg.v22.i26.5971↗
  9. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Last author DOI 10.1002/ijc.29324↗
  10. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells. Last author DOI 10.1002/ijc.28044↗
  11. EpCAM-associated claudin-7 supports lymphatic spread and drug resistance in rat pancreatic cancer. First author DOI 10.1002/ijc.28085↗
  12. Pancreatic cancer diagnosis by free and exosomal miRNA. Co-author DOI 10.4291/wjgp.v4.i4.74↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhe Wang · 6 shared papers, 2016–2025 · strength 1.09
  2. Thilo Hackert · 5 shared papers, 2017–2025 · strength 0.92
  3. Hanxue Sun · 4 shared papers, 2019–2025 · strength 0.83
  4. Ulrike Erb · 2 shared papers, 2016–2017 · strength 0.21
  5. Wei Mu · 1 shared paper, 2019 · strength 0.16
  6. Sarah Heiler · 1 shared paper, 2016 · strength 0.10
  7. Nathalia A. Giese · 2 shared papers, 2013–2015 · strength 0.09
  8. Markus Wolfgang Büchler · 2 shared papers, 2013–2015 · strength 0.09
  9. Li Xiao · 1 shared paper, 2017 · strength 0.09
  10. Florian Thuma · 1 shared paper, 2013 · strength 0.08
  11. Haobin Wang · 1 shared paper, 2013 · strength 0.05
  12. Bindhu K. Madhavan · 1 shared paper, 2015 · strength 0.05
  13. Shijing Yue · 1 shared paper, 2015 · strength 0.05
  14. Holger Kalthoff · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.